In addition, PNT favours post-translational modification of specific chemokines and cytokines (e.g. CCL2 and CSF-2) which have been shown to favour the recruitment and infiltration of anti-tumour T cells as well as they critically alter MHC-peptide complex inhibiting T cell activation [146–148]. The gene discussed is CSF2; the disease is neoplasm.